# Comparative Effects of Doxercalciferol and Calcitriol on Secondary Hyperparathyroidism in ESRD

> **NCT07640347** · NA · NOT_YET_RECRUITING · sponsor: **Chittagong Medical College** · enrollment: 98 (estimated)

## Conditions studied

- Lowering Parathyroid Hormone Level in Patients on Hemodioalysis

## Interventions

- **DRUG:** Doxercalciferol administration
- **DRUG:** oral calcitriol 0.25 microgram

## Key facts

- **NCT ID:** NCT07640347
- **Lead sponsor:** Chittagong Medical College
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-05
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640347, "Comparative Effects of Doxercalciferol and Calcitriol on Secondary Hyperparathyroidism in ESRD". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*